Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Igm Biosciences, Inc. (IGMS)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 24,220,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $ - $
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   IGM Biosciences is a clinical-stage biotechnology company engaging in the development of Immunoglobulin M (IgM) antibodies for the treatment of multiple diseases. Co.'s primary product candidate, IGM-2323, a bispecific T cell engaging IgM antibody targeting CD20 and CD3 proteins. Co.'s second product candidate, IGM-8444, is an IgM antibody targeting Death Receptor 5 proteins. Co.'s pipeline also includes IGM-7354, a bispecific IgM antibody delivering interleukin-15 cytokines to PD-L1 for the treatment of patients with solid and hematologic malignancies; IGM-2644, a bispecific T cell targeting CD38 and CD3 proteins and IGM-2537, a bispecific T cell targeting CD123, and CD3 proteins.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 395,317 928,010 1,130,933 1,203,433
Total Buy Value $3,425,569 $6,857,033 $8,606,797 $9,889,100
Total People Bought 1 1 5 6
Total Buy Transactions 3 6 11 15
Total Shares Sold 28,125 64,791 154,362 286,636
Total Sell Value $281,621 $492,429 $1,355,835 $4,051,715
Total People Sold 6 7 8 8
Total Sell Transactions 12 21 30 62
End Date 2024-02-22 2023-11-21 2023-05-23 2022-05-23

   
Records found: 422
  Page 14 of 17  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Keyt Bruce Chief Scientific Officer   •       –      –    2020-12-17 4 AS $86.10 $139,310 D/D (1,618) 2,769     -
   Keyt Bruce Chief Scientific Officer   •       –      –    2020-12-16 4 D $89.38 $78,833 D/D (882) 4,387     -
   Keyt Bruce Chief Scientific Officer   •       –      –    2020-12-16 4 OE $0.93 $2,325 D/D 2,500 5,269     -
   Topsoe Christina Teng Director   –       •       •   2020-12-11 4 B $90.00 $9,999,990 I/I 111,111 10,400,564 2.25     -
   Topsoe Jakob Haldor Director   –       •       •   2020-12-11 4 B $90.00 $9,999,990 I/I 111,111 10,400,564 2.25     -
   Haldor Topsoe Holding A/s 10% Owner   –       –       •   2020-12-11 4 B $90.00 $9,999,990 D/D 111,111 10,400,564 2.45     -
   Behrens M Kathleen Director   –       •      –    2020-12-11 4 B $90.00 $3,999,960 I/I 44,444 21,111 2.1     -
   Chen Daniel Shinyu Chief Medical Officer   •       –      –    2020-12-08 4 AS $91.00 $110,929 D/D (1,219) 116,473     -
   Chen Daniel Shinyu Chief Medical Officer   •       –      –    2020-12-07 4 D $72.92 $49,659 D/D (681) 117,692     -
   Chen Daniel Shinyu Chief Medical Officer   •       –      –    2020-12-07 4 OE $1.39 $2,641 D/D 1,900 118,373     -
   Chen Daniel Shinyu Chief Medical Officer   •       –      –    2020-12-02 4 AS $63.15 $38,398 D/D (608) 116,473     -
   Chen Daniel Shinyu Chief Medical Officer   •       –      –    2020-12-01 4 D $64.22 $21,963 D/D (342) 117,081     -
   Chen Daniel Shinyu Chief Medical Officer   •       –      –    2020-12-01 4 OE $1.39 $1,321 D/D 950 117,423     -
   Tahir Misbah Chief Financial Officer   •       –      –    2020-11-13 4 A $45.45 $1,909 D/D 42 42     -
   Keyt Bruce Chief Scientific Officer   •       –      –    2020-11-13 4 A $45.45 $5,999 D/D 132 2,769     -
   Schwarzer Fred CEO and President   •       •      –    2020-11-13 4 A $45.45 $13,226 D/D 291 198,105     -
   Chen Daniel Shinyu Chief Medical Officer   •       –      –    2020-11-04 4 AS $50.00 $30,250 D/D (605) 116,473     -
   Chen Daniel Shinyu Chief Medical Officer   •       –      –    2020-11-02 4 D $52.39 $18,075 D/D (345) 117,123     -
   Chen Daniel Shinyu Chief Medical Officer   •       –      –    2020-11-02 4 OE $1.39 $1,321 D/D 950 117,468     -
   Loberg Michael D Director   –       •      –    2020-10-09 4 GA $0.00 $0 I/I 535 1,605     -
   Loberg Michael D Director   –       •      –    2020-10-09 4 GD $0.00 $0 D/D 535 0     -
   Chen Daniel Shinyu Chief Medical Officer   •       –      –    2020-10-02 4 AS $73.50 $134,505 D/D (1,830) 116,518     -
   Chen Daniel Shinyu Chief Medical Officer   •       –      –    2020-10-01 4 D $76.13 $77,653 D/D (1,020) 118,348     -
   Chen Daniel Shinyu Chief Medical Officer   •       –      –    2020-10-01 4 OE $1.39 $3,962 D/D 2,850 119,368     -
   Keyt Bruce Chief Scientific Officer   •       –      –    2020-10-01 4 AS $73.59 $73,590 I/I (1,000) 1,896     -
  422 Records found
  Previous  10  11  12  13  14  15  16  17   
  Page 14 of 17
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us